Article summary
In this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of Ambio Life Sciences β one of the worldβs leading ibogaine clinics β to explore the potential of ibogaine for addiction, neuroregeneration, and how ethics, honoring [β¦] The post <strong>Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson of Ambio Life Sciences</strong> appeared first on Psychedelics Today.
Continue to the original publication for the complete article.